Results 261 to 270 of about 4,652,143 (319)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Alternatively activated neutrophils limit T cell-driven neuroinflammation. [PDF]

open access: yesJ Neuroinflammation
Atkinson JR   +13 more
europepmc   +1 more source

CAR-T cell immunotherapy in rhabdomyosarcoma. [PDF]

open access: yesJ Transl Med
Safarzadeh Kozani P   +2 more
europepmc   +1 more source

Mechanistic basis and therapeutic modulation of T cell fitness to enhance CAR-T cell efficacy in hematological malignancies. [PDF]

open access: yesFront Immunol
Makni-Maalej K   +12 more
europepmc   +1 more source

Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager. [PDF]

open access: yesMol Ther Oncol
Choi MJ   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy